Comments to FDA: Remote Regulatory Assessments Draft Guidance Share page: Docket Number: FDA-2022-D-0810 CHPA appreciates the opportunity to provide comments on FDA Remote Regulatory Assessments Draft Guidance. Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Related Posts Press Releases and Statements CHPA Recognizes International Self-Care Day, Underscores Value of Consumer Healthcare Products Jul 24, 2024 Public Policy & Regulatory Press Releases and Statements Strengthening the Self-Care Community: CHPA Welcomes 15 New Members & Celebrates Longtime Partnerships Jul 22, 2024